CD8A and hepatocellular carcinoma: Moreover, Huang M et al. [119] reported that after treatment, CD4+ cells, CD4+/CD8+ ratio, and NK cells increased in HCC patients; in contrast, CD8+ cells were significantly reduced, offering a strong indication that TACE may improve patients’ immune system.